These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong. Lam YH, Ghosh A, Tang MH, Tang LC, Lee CP, Sin SY, Ho PK. Prenat Diagn; 1998 Jun; 18(6):585-89. PubMed ID: 9664604 [Abstract] [Full Text] [Related]
3. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age. Hsu JJ, Hsieh TT, Soong YK, Spencer K. Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893 [Abstract] [Full Text] [Related]
15. The sensitivity of the trivariate analysis using maternal serum alpha-feto protein, human chorionic gonadotrophin and maternal age in screening for fetal aneuploidy in mothers above the age of 35. Anandakumar C, Chew S, Wong YC, Goh VH, Tain CF, Ratnam SS. J Perinat Med; 1999 Aug; 27(3):178-82. PubMed ID: 10503178 [Abstract] [Full Text] [Related]
19. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy]. Lesin J, Skrablin S, Durić K, Suchanek E, Muzinić D, Kalafatić D, Kuvacić I, Zlopasa G, Plavec A. Lijec Vjesn; 2003 Aug; 125(3-4):55-60. PubMed ID: 12899094 [Abstract] [Full Text] [Related]
20. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome]. Kjaergaard S, Hahnemann JM, Skibsted L, Jensen LN, Sperling L, Zingenberg H, Kristiansen A, Brøndum-Nielsen K. Ugeskr Laeger; 2008 Mar 31; 170(14):1152-6. PubMed ID: 18405480 [Abstract] [Full Text] [Related] Page: [Next] [New Search]